This trade activity should not be overlooked: ADT Inc (ADT)

With 9.45 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.44 million shares. The 52-week range on ADT shows that it touched its highest point at $7.60 and its lowest point at $4.89 during that stretch. It currently has a 1-year price target of $9.66. With its current market cap of 5.89 billion, ADT has annualized dividend of $0.16 while the current yield stands at 2.47%. Beta for the stock currently stands at 1.58.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ADT was up-trending over the past week, with a rise of 1.56%, but this was down by -10.61% over a month. Three-month performance dropped to -5.12% while six-month performance rose 6.05%. The stock lost -9.61% in the past year, while it has lost -4.84% so far this year. A look at the trailing 12-month EPS for ADT yields 0.46 with Next year EPS estimates of 0.79. For the next quarter, that number is 0.15. This implies an EPS growth rate of 27.94% for this year and 20.80% for next year. EPS is expected to grow by 3.90% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 25.80%.

Float and Shares Shorts:

At present, 867.43 million ADT shares are outstanding with a float of 385.01 million shares on hand for trading. On Mar 15, 2024, short shares totaled 13.51 million, which was 1.47% higher than short shares on Feb 15, 2024. In addition to ACT as the firm’s AdvisorShares Vice ETF, ALT serves as its Altimmune, Inc.

Institutional Ownership:

Through their ownership of 94.13% of ADT’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ADT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.